Saving Faces are working closely with Dendrite Clinical Systems Ltd. to deliver a new national head and neck cancer audit (HANA). HANA aims to assess the process of care and its outcomes in patients diagnosed with new primary or recurrent head and neck cancer in England and Wales and to improve the quality of services and the outcomes achieved for patients. Visit our HANA website for more information.
Last updated: July 2017
Saving Faces is funding three PhD studentships. They will be carrying out innovative projects in collaboration with Professor Ania Korszun (Professor of Psychiatry and Education), Dr Muy-Teck Teh (Senior Lecturer in Head & Neck Cancer) and Dr Ahmad Waseem (Reader in Oral Biology).
Radiotherapy is an essential treatment approach in head and neck cancer. Many patients are offered radiotherapy or chemoradiotherapy following successful surgical tumour resection, but there are many complications associated with this treatment, and there is little evidence to determine if adding radiotherapy in this situation will give any survival benefit. This study will compare the genetic profile of patients with and without severe swallowing difficulties following radiotherapy and try to identify genetic factors associated with a higher risk of developing severe complications.
UPDATE 27/07/15: This trial is now closed to recruitment. We will be publishing the results in the near future. Please check back soon or This email address is being protected from spambots. You need JavaScript enabled to view it. for more information
Saving Faces researchers are working on a Cancer Research UK funded study which is the first large scale surgical clinical trial in the United Kingdom for patients with oral cancer. The trial will involve over 600 patients nationwide and aims to answer important questions in the treatment of patients with oral cancer that will benefit both patients and the NHS.
 |
|
